Katsuji Shinagawa

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Shigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita et al. · Blood · 2010 · 262 citations · Full text

Medicine, Oncology, Pharmacology +15

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

Jin Takeuchi, Taiichi Kyo, K Naito et al. · Leukemia · 2002 · 188 citations

Medicine, Oncology, Pharmacology +14

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Shuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa et al. · Blood · 2010 · 175 citations · Full text

Medicine, Oncology, Pharmacology +15

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy: The Japan Adult Leukemia Study Group (JALSG) APL97 study

Norio Asou, Yuji Kishimoto, Hitoshi Kiyoi et al. · Blood · 2007 · 156 citations · Full text

Medicine, Hematology, Oncology +15

Hepatic toxicity and prognosis in hepatitis C virus–infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

Daisuke Ennishi, Yoshinobu Maeda, Nozomi Niitsu et al. · Blood · 2010 · 153 citations · Full text

Medicine, Hematology, Oncology +16